Filing Details

Accession Number:
0001140361-24-009033
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-22 16:07:12
Reporting Period:
2024-02-20
Accepted Time:
2024-02-22 16:07:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887359 Vericel Corp VCEL Biological Products, (No Disgnostic Substances) (2836) 943096597
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1220363 Md L Robert Zerbe C/O Vericel Corporation
64 Sidney Street
Cambridge MA 02139
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-20 722 $3.74 24,117 No 4 M Direct
Common Stock Disposition 2024-02-20 722 $50.01 23,395 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2024-02-20 722 $0.00 722 $3.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,278 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023.
  2. These options, representing the right to purchase 4,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015.
  3. These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.